• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

燕麦来源的β-葡聚糖可显著提高轻度高胆固醇血症超重个体的高密度脂蛋白胆固醇(HDLC)水平,并降低低密度脂蛋白胆固醇(LDLC)和非高密度脂蛋白胆固醇水平。

Oat-derived beta-glucan significantly improves HDLC and diminishes LDLC and non-HDL cholesterol in overweight individuals with mild hypercholesterolemia.

作者信息

Reyna-Villasmil Nadia, Bermúdez-Pirela Valmore, Mengual-Moreno Edgardo, Arias Nelly, Cano-Ponce Clímaco, Leal-Gonzalez Elliuz, Souki Aida, Inglett George E, Israili Zafar H, Hernández-Hernández Rafael, Valasco Manuel, Arraiz Naikt

机构信息

Center for Metabolic and Endocrine Research, The University of Zulia, Maracaibo, Venezuela.

出版信息

Am J Ther. 2007 Mar-Apr;14(2):203-12. doi: 10.1097/01.pap.0000249917.96509.e7.

DOI:10.1097/01.pap.0000249917.96509.e7
PMID:17414591
Abstract

OBJECTIVE

To investigate the effect of bread formulated with 6 g of beta-glucan (oat soluble fiber) on serum lipids in overweight normotensive subjects with mild to moderate hypercholesterolemia.

DESIGN

Thirty-eight male subjects [mean age 59.8 +/- 0.6 yr, mean body mass index (BMI) 28.3 +/- 0.6 kg/m(2)] who were eligible for the study ate an isocaloric diet for a 1-week period. They were then divided into 2 groups: group A (n = 19), who were maintained on American Heart Association (AHA) Step II diet, including whole wheat bread, and group B (n = 19), who were maintained on AHA Step II diet containing high levels of monounsaturated fatty acids plus bread containing 6 g of beta-glucan (Nutrim-OB) for 8 weeks. Plasma lipids and glucose were measured at baseline and after weeks 8 in all subjects. All subjects were advised to walk for 60 minutes every day.

RESULTS

There was a significant increase (upward arrow 27.8%) in plasma high density lipoprotein (HDL) cholesterol in the beta-glucan group (group A) from 39.4 +/- 2.0 to 49.5 +/- 2.1 mg/dL (P < 0.001), but there was no change in group B. There was a significant reduction in total cholesterol in the 2 groups to approximately the same extent: group A, from 232.8 +/- 2.7 mg/dL to 202.7 +/- 6.7 mg/dL; P < 0.001; and group B, from 231.8 +/- 4.3 mg/dL to 194.2 +/- 4.3 mg dL; P < 0.001. Plasma low density lipoprotein (LDL) cholesterol also decreased significantly in the two groups: group A, from 160.3 +/- 2.8 mg/dL to 133.2 +/- 5.4 mg/dL; P < 0.001; group B, from 167.9 +/- 4.3 mg/dL to 120.9 +/- 4.3 mg/dL; P < 0.001; however, the beta-glucan fortified diet was significantly more effective (downward arrow 27.3% vs. downward arrow 16.8%; P < 0.04). There was a small and insignificant reduction in plasma very LDL (VLDL) cholesterol and triglycerides in the two groups. Similarly, non-HDL cholesterol levels were also decreased, with beta-glucan diet producing significantly higher effect (downward arrow 24.5% vs. downward arrow 16.1%; P < 0.04). The beta-glucan diet also produced higher reduction in total cholesterol/HDL cholesterol ratio (downward arrow 33.3% vs. downward arrow 8.4%; P < 0.003) and LDL cholesterol/HDL cholesterol ratio (downward arrow 42.1% vs. downward arrow 13.3%; P < 0.001) than the diet without beta-glucan. The beta-glucan diet also decreased fasting plasma glucose (P < 0.4), whereas the other diet had no effect. Interestingly, both diets reduced body weight and BMI significantly, with beta-glucan diet having a greater effect.

CONCLUSIONS

Six grams of beta-glucan from oats added to the AHA Step II diet and moderate physical activity improved lipid profile and caused a decrease in weight and, thus, reduced the risk of cardiovascular events in overweight male individuals with mild to moderate hypercholesterolemia. The diet with added beta-glucan was well accepted and tolerated.

摘要

目的

研究添加6克β-葡聚糖(燕麦可溶性纤维)的面包对轻度至中度高胆固醇血症的超重血压正常受试者血脂的影响。

设计

38名符合研究条件的男性受试者[平均年龄59.8±0.6岁,平均体重指数(BMI)28.3±0.6kg/m²]在1周内食用等热量饮食。然后他们被分为两组:A组(n = 19),维持美国心脏协会(AHA)第二步饮食,包括全麦面包;B组(n = 19),维持AHA第二步饮食,其中含有高水平的单不饱和脂肪酸,外加含有6克β-葡聚糖的面包(Nutrim-OB),持续8周。在基线时以及所有受试者第8周后测量血浆脂质和葡萄糖。建议所有受试者每天步行60分钟。

结果

β-葡聚糖组(A组)血浆高密度脂蛋白(HDL)胆固醇显著升高(上升27.8%),从39.4±2.0mg/dL升至49.5±2.1mg/dL(P < 0.001),而B组无变化。两组总胆固醇均有显著降低,且降低程度大致相同:A组,从232.8±2.7mg/dL降至202.7±6.7mg/dL;P < 0.001;B组,从231.8±4.3mg/dL降至194.2±4.3mg/dL;P < 0.001。两组血浆低密度脂蛋白(LDL)胆固醇也显著降低:A组,从160.3±2.8mg/dL降至133.2±5.4mg/dL;P < 0.001;B组,从167.9±4.3mg/dL降至120.9±4.3mg/dL;P < 0.001;然而,添加β-葡聚糖的饮食效果显著更佳(下降27.3%对下降16.8%;P < 0.04)。两组血浆极低密度脂蛋白(VLDL)胆固醇和甘油三酯有小幅且不显著的降低。同样,非HDL胆固醇水平也降低,添加β-葡聚糖的饮食效果显著更高(下降24.5%对下降16.1%;P < 0.04)。与不含β-葡聚糖的饮食相比,β-葡聚糖饮食在总胆固醇/HDL胆固醇比值(下降33.3%对下降8.4%;P < 0.003)和LDL胆固醇/HDL胆固醇比值(下降42.1%对下降13.3%;P < 0.001)方面降低幅度也更大。β-葡聚糖饮食还降低了空腹血糖(P < 0.4),而另一种饮食则无此效果。有趣的是,两种饮食均显著降低了体重和BMI,添加β-葡聚糖的饮食效果更佳。

结论

在AHA第二步饮食中添加6克燕麦β-葡聚糖并进行适度体育活动可改善血脂状况,减轻体重,从而降低轻度至中度高胆固醇血症超重男性个体发生心血管事件的风险。添加β-葡聚糖的饮食耐受性良好且易于接受。

相似文献

1
Oat-derived beta-glucan significantly improves HDLC and diminishes LDLC and non-HDL cholesterol in overweight individuals with mild hypercholesterolemia.燕麦来源的β-葡聚糖可显著提高轻度高胆固醇血症超重个体的高密度脂蛋白胆固醇(HDLC)水平,并降低低密度脂蛋白胆固醇(LDLC)和非高密度脂蛋白胆固醇水平。
Am J Ther. 2007 Mar-Apr;14(2):203-12. doi: 10.1097/01.pap.0000249917.96509.e7.
2
Whole-grain ready-to-eat oat cereal, as part of a dietary program for weight loss, reduces low-density lipoprotein cholesterol in adults with overweight and obesity more than a dietary program including low-fiber control foods.作为减肥饮食计划的一部分,全谷物即食燕麦片比包含低纤维对照食品的饮食计划更能降低超重和肥胖成年人的低密度脂蛋白胆固醇。
J Am Diet Assoc. 2010 Feb;110(2):205-14. doi: 10.1016/j.jada.2009.10.037.
3
Ciprofibrate treatment decreases non-high density lipoprotein cholesterol and triglycerides and increases high density lipoprotein cholesterol in patients with Frederickson type IV dyslipidemia phenotype.环丙贝特治疗可降低弗雷德里克森IV型血脂异常表型患者的非高密度脂蛋白胆固醇和甘油三酯水平,并提高高密度脂蛋白胆固醇水平。
Am J Ther. 2007 Mar-Apr;14(2):213-20. doi: 10.1097/01.pap.0000249920.70815.2d.
4
Oat bran concentrate bread products improve long-term control of diabetes: a pilot study.燕麦麸浓缩物面包产品改善糖尿病的长期控制:一项试点研究。
J Am Diet Assoc. 1996 Dec;96(12):1254-61. doi: 10.1016/S0002-8223(96)00329-X.
5
Cholesterol-lowering benefits of oat-containing cereal in Hispanic americans.含燕麦谷物对美国西班牙裔人群的降胆固醇益处。
J Am Diet Assoc. 2005 Jun;105(6):967-70. doi: 10.1016/j.jada.2005.03.006.
6
Serum lipids and postprandial glucose and insulin levels in hyperlipidemic subjects after consumption of an oat beta-glucan-containing ready meal.高脂血症患者食用含燕麦β-葡聚糖即食餐餐后的血脂、餐后血糖和胰岛素水平
Ann Nutr Metab. 2008;52(2):83-90. doi: 10.1159/000121281. Epub 2008 Mar 11.
7
Oat beta-glucan reduces blood cholesterol concentration in hypercholesterolemic subjects.燕麦β-葡聚糖可降低高胆固醇血症患者的血液胆固醇浓度。
Eur J Clin Nutr. 1994 Jul;48(7):465-74.
8
A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.一项为期52周的随机、开放标签、平行组比较研究,旨在观察匹伐他汀和阿托伐他汀对日本低密度脂蛋白胆固醇水平升高且伴有糖耐量异常患者的高密度脂蛋白胆固醇水平及糖代谢的耐受性和影响。
Clin Ther. 2008 Jun;30(6):1089-101. doi: 10.1016/j.clinthera.2008.05.017.
9
Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.空军/德克萨斯冠状动脉粥样硬化预防研究(AFCAPS/TexCAPS)队列亚组筛查期间血清低密度脂蛋白胆固醇水平的不稳定性。
J Am Osteopath Assoc. 2002 Jul;102(7):377-84.
10
Beta-glucan- or rice bran-enriched foods: a comparative crossover clinical trial on lipidic pattern in mildly hypercholesterolemic men.富含β-葡聚糖或米糠的食物:轻度高胆固醇血症男性血脂模式的比较交叉临床试验。
Eur J Clin Nutr. 2011 Jul;65(7):864-71. doi: 10.1038/ejcn.2011.48. Epub 2011 Apr 20.

引用本文的文献

1
Comparison of Low-Gluten Diets Rich in Oats or Rice-A 6-Week Randomized Clinical Trial With Metabolically Challenged Volunteers.富含燕麦或大米的低麸质饮食比较——一项针对代谢有挑战的志愿者的为期6周的随机临床试验。
Mol Nutr Food Res. 2025 Jun;69(12):e70076. doi: 10.1002/mnfr.70076. Epub 2025 May 7.
2
Activation of Immune and Antiviral Effects by Extracts: A Review.提取物对免疫和抗病毒作用的激活:综述
Foods. 2023 Dec 11;12(24):4438. doi: 10.3390/foods12244438.
3
Dietary Supplements Containing Oat Beta-Glucan and/or Green Coffee (Poly)phenols Showed Limited Effect in Modulating Cardiometabolic Risk Biomarkers in Overweight/Obese Patients without a Lifestyle Intervention.
含有燕麦β-葡聚糖和/或绿咖啡(多)酚的膳食补充剂在不进行生活方式干预的超重/肥胖患者中调节心血管代谢风险生物标志物的效果有限。
Nutrients. 2023 May 8;15(9):2223. doi: 10.3390/nu15092223.
4
Metabolomic Characteristics of Cecum Contents in High-Fat-Diet-Induced Obese Mice Intervened with Different Fibers.不同纤维干预的高脂饮食诱导肥胖小鼠盲肠内容物的代谢组学特征
Foods. 2023 Mar 26;12(7):1403. doi: 10.3390/foods12071403.
5
Dietary-Nutraceutical Properties of Oat Protein and Peptides.燕麦蛋白和肽的膳食营养特性。
Front Nutr. 2022 Jul 5;9:950400. doi: 10.3389/fnut.2022.950400. eCollection 2022.
6
Effects of Oat Beta-Glucan Intake on Lipid Profiles in Hypercholesterolemic Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.燕麦β-葡聚糖摄入对高胆固醇血症成人血脂谱的影响:系统评价和随机对照试验的荟萃分析。
Nutrients. 2022 May 13;14(10):2043. doi: 10.3390/nu14102043.
7
Regular Consumption of Green Coffee Phenol, Oat β-Glucan and Green Coffee Phenol/Oat β-Glucan Supplements Does Not Change Body Composition in Subjects with Overweight and Obesity.经常食用绿咖啡酚、燕麦β-葡聚糖以及绿咖啡酚/燕麦β-葡聚糖补充剂不会改变超重和肥胖受试者的身体成分。
Foods. 2022 Feb 25;11(5):679. doi: 10.3390/foods11050679.
8
Gamma-Irradiation-Induced Degradation of the Water-Soluble Polysaccharide from and Its Anti-Hypercholesterolemic Activity.辐照诱导对 和水溶性多糖的降解及其抗高胆固醇活性的影响。
Molecules. 2022 Feb 7;27(3):1110. doi: 10.3390/molecules27031110.
9
Management of Hypercholesterolemia Through Dietary ß-glucans-Insights From a Zebrafish Model.通过膳食β-葡聚糖管理高胆固醇血症——来自斑马鱼模型的见解
Front Nutr. 2022 Jan 12;8:797452. doi: 10.3389/fnut.2021.797452. eCollection 2021.
10
Lentinan Protects against Nonalcoholic Fatty Liver Disease by Reducing Oxidative Stress and Apoptosis via the PPARα Pathway.香菇多糖通过PPARα途径减轻氧化应激和细胞凋亡来预防非酒精性脂肪性肝病。
Metabolites. 2022 Jan 10;12(1):55. doi: 10.3390/metabo12010055.